Value here for contrarians. Market cap of $3.6m, NPAT $0.75m (all from second half). Debt reducing and appears under control. Revenue $67m. Order book similar to same time last year, supported by promising contract pipeline and probable recurring revenue (not included in order book). Liquidity something of an issue for now, but will likely improve once s.p. turns.